Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fabio Sanna


Postdoctoral Research Scientist

My scientific career begins in 2009 as PhD Student in Biomedical Sciences at the University of Chieti (Italy). During my PhD I was mainly interested in oxidative stress and its relationship with cancer cells proliferation.

In 2014, as a Marie Curie Postdoctoral fellow, I had the opportunity to join the Department of Cardiovascular Medicine, University of Oxford (United Kingdom). This appointment provided an excellent opportunity to engage with translational research, where I could apply my skills as molecular biologist to understand the basics of atherosclerosis in the contest of cross-talk between adipose tissue and vascular wall.

In 2018 my research interest moved towards human metabolism and liver patho-physiology. In the same year I joined the pharmaceutical company Novo Nordisk, in the department of Discovery Technologies and Genomics. I am currently working as Postdoctoral Research Associated Fellow in Prof. David Ray’s group at University of Oxford (OCDEM RDM), in a research programme funded by MRC. In this particular project I am focusing on the relation between circadian rhythm, inflammation and metabolism re-modelling. By using in vitro models such as 3D cell culture and molecular biology techniques like ChIPseq and RNAseq, my research focuses on the role of a wide range of molecules serving as a link to mediate temporal distribution of metabolic processes. 

Recent publications

More publications